tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals Signs Agreement with Kaken Pharmaceutical
PremiumCompany AnnouncementsKalVista Pharmaceuticals Signs Agreement with Kaken Pharmaceutical
2M ago
KalVista subsidiary licenses commercialization rights for sebetralstat in Japan
Premium
The Fly
KalVista subsidiary licenses commercialization rights for sebetralstat in Japan
2M ago
KalVista Pharmaceuticals’ Strategic Readiness and Market Potential Drive Buy Rating for Sebetralstat
Premium
Ratings
KalVista Pharmaceuticals’ Strategic Readiness and Market Potential Drive Buy Rating for Sebetralstat
2M ago
Promising Potential of Sebetralstat: A Game-Changer in Hereditary Angioedema Treatment
PremiumRatingsPromising Potential of Sebetralstat: A Game-Changer in Hereditary Angioedema Treatment
3M ago
Buy Rating for KalVista Pharmaceuticals Driven by Anticipated FDA Approval and Strong Market Position
Premium
Ratings
Buy Rating for KalVista Pharmaceuticals Driven by Anticipated FDA Approval and Strong Market Position
3M ago
KalVista Pharmaceuticals Advances Sebetralstat for HAE
Premium
Company Announcements
KalVista Pharmaceuticals Advances Sebetralstat for HAE
3M ago
KALV Earnings this Week: How Will it Perform?
PremiumPre-EarningsKALV Earnings this Week: How Will it Perform?
3M ago
KalVista Pharmaceuticals’ Sebetralstat: A Game-Changer in Oral HAE Treatment with Strong Market Potential
Premium
Ratings
KalVista Pharmaceuticals’ Sebetralstat: A Game-Changer in Oral HAE Treatment with Strong Market Potential
3M ago
KalVista initiated with an Outperform at JMP Securities
Premium
The Fly
KalVista initiated with an Outperform at JMP Securities
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100